Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys
Frederick J. Angulo, Lyn Finelli, David L. Swerdlow
JAMA Network Open (2021) Vol. 4, Iss. 1, pp. e2033706-e2033706
Open Access | Times Cited: 138

Showing 51-75 of 138 citing articles:

Underreporting of Cases in the COVID-19 Outbreak of Borriana (Spain) During Mass Gathering Events in March 2020: A Cross-Sectional Study.
Salvador Domènech-Montoliy, María Rosario Pac-Sa, Diego Sala-Trull, et al.
(2024)
Open Access | Times Cited: 1
Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study
Chad R. Wells, Abhishek Pandey, Meagan C. Fitzpatrick, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 12
Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms
Juan Manuel Carreño, Damodara Rao Mendu, Viviana Simon, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 102937-102937
Open Access | Times Cited: 12
Detection of Neutralizing Antibodies against SARS-CoV-2 Post-Vaccination in Health Care Workers of a Large Tertiary Hospital in Spain by Using a Rapid Test LFIC and sVNT-ELISA
José Tuells, Mónica Parra-Grande, Francisco J. Santos-Calle, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 510-510
Open Access | Times Cited: 8
Educational futures after COVID-19: Big tech and pandemic profiteering versus education for democracy
Trevor Norris
Policy Futures in Education (2022) Vol. 21, Iss. 1, pp. 34-57
Closed Access | Times Cited: 8
Ecological studies of COVID-19 and air pollution: How useful are they?
Paul J. Villeneuve, Mark S. Goldberg
Environmental Epidemiology (2022) Vol. 6, Iss. 1, pp. e195-e195
Open Access | Times Cited: 8
Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers
Agata Błaszczuk, Aleksander Michalski, Maria Malm, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1169-1169
Open Access | Times Cited: 8
SARS‐CoV‐2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study
Mai Mahmoud, Houssein H. Ayoub, Peter Coyle, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 11
Open Access | Times Cited: 4
Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
Alireza FakhriRavari, Mazyar Malakouti
(2024)
Open Access | Times Cited: 1
Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
Alireza FakhriRavari, Mazyar Malakouti
Pharmacoepidemiology (2024) Vol. 3, Iss. 1, pp. 69-81
Open Access | Times Cited: 1
Bayesian hierarchical spatiotemporal models for prediction of (under)reporting rates and cases: COVID-19 infection among the older people in the United States during the 2020–2022 pandemic
Jingxin Lei, Ying C. MacNab
Spatial and Spatio-temporal Epidemiology (2024) Vol. 49, pp. 100658-100658
Open Access | Times Cited: 1
Incidence of symptomatic Borrelia burgdorferi sensu lato infection in Romania, 2018−2023
Frederick J. Angulo, Julia Olsen, Veronica Purdel, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Using a population-based Kalman estimator to model the COVID-19 epidemic in France: estimating associations between disease transmission and non-pharmaceutical interventions
Annabelle Collin, Boris P. Hejblum, Carole Vignals, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 11
Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July–August 2020: a mail-based cross-sectional study
Teah Snyder, Johanna Ravenhurst, Estee Y. Cramer, et al.
BMJ Open (2021) Vol. 11, Iss. 8, pp. e051157-e051157
Open Access | Times Cited: 11
Near real time monitoring and forecasting for COVID-19 situational awareness
Robert Stewart, Samantha Erwin, Jesse Piburn, et al.
Applied Geography (2022) Vol. 146, pp. 102759-102759
Open Access | Times Cited: 7
An international comparison of anti‐SARS‐COV‐2 assays used for seroprevalence surveys from blood component providers
Antoine Lewin, Steven J. Drews, Ryanne W. Lieshout‐Krikke, et al.
Vox Sanguinis (2021) Vol. 116, Iss. 9, pp. 946-954
Open Access | Times Cited: 10
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021
Jackie Kleynhans, Stefano Tempia, Nicole Wolter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
Estimates of Presumed Population Immunity to SARS-CoV-2 by State in the United States, August 2021
Marie C. D. Stoner, Frederick J. Angulo, Sarah Rhea, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 2
Open Access | Times Cited: 6
When Do Epidemics End? Scientific Insights from Mathematical Modelling Studies
Natalie M. Linton, Francesca A. Lovell-Read, Emma Southall, et al.
Centaurus (2022) Vol. 64, Iss. 1, pp. 31-60
Open Access | Times Cited: 6
Trend of expansion of SARS-CoV-2 infection and COVID-19 burden in Gabon (Central Africa) in mid-2021, based on a serological survey
Berthe Amélie Iroungou, Pamela Moussavou-Boundzanga, Éric Elguero, et al.
IJID Regions (2022) Vol. 5, pp. 13-17
Open Access | Times Cited: 6
Better Metrics to Guide Public Health Policy: Lessons Learned From COVID-19 for Data Systems Improvement
­Michael A. Stoto, John D. Kraemer, Rachael Piltch‐Loeb
Harvard data science review (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 3
Optimal spatial evaluation of a pro rata vaccine distribution rule for COVID-19
F. Castonguay, Julie C. Blackwood, Emily Howerton, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area
Christina Lindan, Manisha Desai, Derek Boothroyd, et al.
Annals of Epidemiology (2021) Vol. 67, pp. 81-100
Open Access | Times Cited: 8
Prognostic factors associated with COVID-19 related severity in sickle cell disease
Nalan Yurtsever, Vijay Nandi, Yonah Ziemba, et al.
Blood Cells Molecules and Diseases (2021) Vol. 92, pp. 102627-102627
Open Access | Times Cited: 8
Adjusting COVID-19 Seroprevalence Survey Results to Account for Test Sensitivity and Specificity
Mark J. Meyer, Shuting Yan, Samantha Schlageter, et al.
American Journal of Epidemiology (2021) Vol. 191, Iss. 4, pp. 681-688
Open Access | Times Cited: 8

Scroll to top